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Abstract: This present investigation deals with the development and optimization of polymeric 
nanoparticle systems loaded with 3,5,3′-triiodothyroacetic acid (Triac). A 211–6 fractional factorial 
design and another 22 factorial design were used to study the contrasts on particle size distribu-
tion, morphology, surface charge, drug content, entrapment efficiency, and in vitro drug release 
profiles. The independent variables were the concentration of Triac, type and quantity of both 
polymer and oil, quantity of Span™ 60 and Tween® 80, volume of solvent and water, and veloc-
ity of both magnetic stirring and the transfer of the organic phase into the aqueous solution. The 
results of optimized formulations showed a narrow size distribution with a polydispersity index 
lower than 0.200. The particle sizes were on average 159.6 nm and 285.6 nm for nanospheres 
and nanocapsules, respectively. The zeta potential was higher than 20 mV (in module) and the 
entrapment efficiency was nearly 100%. A high-performance liquid chromatography method 
was developed, validated, and efficiently applied to Triac quantification in colloidal suspension. 
The main independent variables were the type and quantity of the polymer and oil. In vitro drug 
release profile depicted several features to sustain Triac release. Different formulations showed 
various release rates indicating an interaction between Triac and other formulation compounds 
such as polymer and/or oil quantity. Two different models were identified (biexponential and 
monoexponential) that allowed the control of both the release rate and Triac concentration. 
Thus, the prepared nanoparticles described here may be of clinical importance in delivering 
Triac for thyroid treatment.
Keywords: Triac, nanoparticles, optimization, factorial design of experiments, HPLC  analytical 
method
Introduction
Thyroid hormone receptors (TRs) are members of the nuclear receptor superfamily that 
are activated by the binding of thyroid hormones.1 They are essential for the develop-
ment of several organs, including the central nervous system, skeleton, heart, intestine, 
skeletal muscle, and sensory organs. Moreover, TRs also have important regulatory 
effects on oxygen consumption and metabolic rate.2 The 3,5,3′-L-triiodothyronine 
(T
3
), and L-thyroxine are the most abundant thyroid hormones.1 There are several 
diseases related to TRs, notably the syndrome of resistance to thyroid hormone that 
is an inherited endocrine human disease characterized by a reduced responsive-
ness of target tissues to thyroid hormone. Resistance to thyroid hormone is usually 
caused by a mutation in the TRβ gene.2,3 The mutations have been described in the 
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carboxyl-terminus of TRβ, in three hot spot areas of the 
ligand-binding and hinge domains.3,4
3,5,3′-triiodothyroacetic acid (Triac), a naturally-
occurring T
3
 analog, has been used on an empirical basis 
to treat the syndrome of resistance to thyroid hormone in 
goitrous patients, in some subjects with thyroid cancer, 
and in thyroidectomized patients, in order to achieve better 
thyroid-stimulating hormone suppression without symptoms 
of thyrotoxicosis.5 It has been reported that Triac binds to 
TRs with higher affinity than T
3
, but it has a very short 
residence time on nuclear receptors and a short plasmatic 
half-life.5,6 Furthermore, Triac shows little solubility in water. 
 Therefore, high daily doses are necessary. Triac concentra-
tions may be up to 200 times the physiological concentration 
of T
3
.7 On the other hand, high concentrations may cause 
various  undesirable effects such as an increase of the heart 
rate and induction of arrhythmias, which might limit Triac’s 
 usefulness.8 The solutions to these problems are among the 
main reasons for the development of new formulations such 
as polymeric nanoparticle systems.
Thus, it would be desirable to develop compounds, tech-
niques, or formulations that could elicit beneficial effects 
while avoiding the deleterious actions. In order to achieve 
such purpose, there are several studies upon nanoparticles 
that highlight these subjects. Nanoparticles have been used 
to increase bioavailability, sustain, localize, or target drug 
action in the body.9 These carrier systems have been proposed 
for controlled delivery of drugs.
Nanoparticles have showed satisfactory therapeutic 
potential and greater stability in biologic fluids as well as 
during storage.10 They have been used for several reasons: 
(a) improvement of the bioavailability of drugs with poor 
adsorption characteristics, (b) prolongation of the residence 
time of drugs in the body, (c) control of the release of the 
drugs, (d) targeting of therapeutic agents to a particular organ 
or tissue and thus reducing toxicity, and (e) improvement of 
the drug stability.11
In order to use drugs safely in the body, various car-
rier systems have been proposed by using biodegradable 
polymers as poly(ε-caprolactone) (PCL), polylactide, 
and polyglycolide. These polymeric materials are usually 
biocompatible, nonantigenic, and highly hydrophobic in 
nature.12 For example, PCL and poly(methyl methacrylate) 
(PMMA) are biocompatible polyesters, which have been 
widely used in drug delivery applications. They have some 
desirable characteristics such as being resistant to chemical 
hydrolysis, achiral, high permeability for many drugs, and 
lack of toxicity.9
In the present work, Triac was entrapped in both PCL 
and PMMA nanoparticles. The nanoparticles of Triac were 
prepared by interfacial polymer deposition following solvent 
displacement, known as nanoprecipitation method, which was 
proposed by Fessi et al.13 Problems in formulation,  delivery, 
and release characteristics of Triac are among the reasons 
for this study. The optimized formulation was identified by 
using two factorial designs. Firstly, a 211–6 fractional facto-
rial design was carried out. Secondly, the best formulation 
went through a specific adjustment according to another 22 
factorial design. Factorial designs are commonly adopted in 
pharmaceutical research that is concerned with the effects 
of formulation variables and their interactions on response 
variables; this is because they yield the most information 
from fewer experiments.14
Material and methods
Reagents and chemicals
Triac was obtained from Sigma-Aldrich Chemie GmbH 
(Steinheim, Germany). The polymers PCL (average molecu-
lar weight 65,000 Da) and PMMA (average molecular weight 
120,000 Da), and the sorbitan monostearate (Span™ 60) were 
bought from Sigma-Aldrich. Polysorbate 80 (Tween® 80) and 
isodecyl oleate were obtained from Importadora Quimica 
Delaware (Porto Alegre, Brazil). The phosphoric acid, sodium 
chloride, potassium chloride, disodium hydrogen phosphate, 
and potassium dihydrogen phosphate were obtained from J 
T Baker (Ecatepec, Mexico). The neem oil was provided 
by Barauna Comercio Industria LTDA (Catanduva, Bra-
zil). All organic solvents used were high-performance 
liquid chromatography (HPLC) grade purchased from 
J T Baker. Purified water (18 MΩ) was obtained by a reverse 
osmosis Milli-Q® system model UV plus ultra-low organics 
water (Millipore Corporation, Bedford, MA).
Preparation of nanoparticles
The nanoparticles were prepared through the method 
of solvent displacement involving the precipitation of a 
 preformed polymer (nanoprecipitation) proposed by Fessi 
et al.13 Briefly, an exact quantity of polymer, Triac, Span 60, 
and oil (only in nanocapsules) were accurately weighed and 
dissolved in acetone at 45°C. Then, the organic phase was 
poured into Tween 80 aqueous solution, which was under 
moderate magnetic stirring, by using a peristaltic pump 
at 10% (PumpPro® TPM 600 55RPM; Watson-Marlow 
Pumps Group, Wilmington, MA) at ambient temperature. 
In due course, the colloidal suspension was maintained for 
10 minutes under moderate magnetic stirring. Subsequently, 
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the solvent and excess of water were removed by using a 
rotary evaporator (Rotovapor® R-210, Buchi Labortechnik 
AG, Flawil, Switzerland). The formulations are described in 
Tables 1 and 2. The final volume of each colloidal dispersion 
was fixed in 100 mL.
Experimental design
The experiments were performed with the  nanoprecipitation 
method by using a fractional factorial design. Eleven 
independent variables were studied in two levels: low and 
high, which were represented by the normalized values 
of −1 and +1, respectively. The independent variables were: 
 concentration of Triac, type and quantity of both polymer 
and oil, quantity of Span 60 and Tween 80, volume of 
solvent and water, and velocity of both magnetic stirring 
and the transfer of the organic phase into the aqueous 
solution. The  experiment was fractioned in 211–6, resulting 
in 32  formulations. The experimental setup of these selected 
variables is shown in Table 1. The dependent variables 
investigated were: pH, particle size, zeta potential, Triac 
absolute recovery, and Triac entrapment eff iciency. 
Microsoft Office Excel® 2007 (Microsoft  Corporation, 
Redmond, WA) was used for the analysis of contrast values 
between factors. The repeatability in the nanoparticle 
Table 1 Values and coded units of 211–6 fractional factorial design for the preparation of 3,5,3′-triiodothyroacetic acid-loaded 
nanoparticles by the nanoprecipitation method
Exp A B C D E ABCDE = F ABCD = G ABCE = H ABDE = I ACE = J BCDE = K
1 −1 −1 −1 −1 −1 −1 1 1 1 1 1
2 1 −1 −1 −1 −1 1 −1 −1 −1 −1 1
3 −1 1 −1 −1 −1 1 −1 −1 −1 1 −1
4 1 1 −1 −1 −1 −1 1 1 1 −1 −1
5 −1 −1 1 −1 −1 1 −1 −1 1 −1 −1
6 1 −1 1 −1 −1 −1 1 1 −1 1 −1
7 −1 1 1 −1 −1 −1 1 1 −1 −1 1
8 1 1 1 −1 −1 1 −1 −1 1 1 1
9 −1 −1 −1 1 −1 1 −1 1 −1 −1 −1
10 1 −1 −1 1 −1 −1 1 −1 1 1 −1
11 −1 1 −1 1 −1 −1 1 −1 1 −1 1
12 1 1 −1 1 −1 1 −1 1 −1 1 1
13 −1 −1 1 1 −1 −1 1 −1 −1 1 1
14 1 −1 1 1 −1 1 −1 1 1 −1 1
15 −1 1 1 1 −1 1 −1 1 1 1 −1
16 1 1 1 1 −1 −1 1 −1 −1 −1 −1
17 −1 −1 −1 −1 1 1 1 −1 −1 −1 −1
18 1 −1 −1 −1 1 −1 −1 1 1 1 −1
19 −1 1 −1 −1 1 −1 −1 1 1 −1 1
20 1 1 −1 −1 1 1 1 −1 −1 1 1
21 −1 −1 1 −1 1 −1 −1 1 −1 1 1
22 1 −1 1 −1 1 1 1 −1 1 −1 1
23 −1 1 1 −1 1 1 1 −1 1 1 −1
24 1 1 1 −1 1 −1 −1 1 −1 −1 −1
25 −1 −1 −1 1 1 −1 −1 −1 1 1 1
26 1 −1 −1 1 1 1 1 1 −1 −1 1
27 −1 1 −1 1 1 1 1 1 −1 1 −1
28 1 1 −1 1 1 −1 −1 −1 1 −1 −1
29 −1 −1 1 1 1 1 1 1 1 −1 −1
30 1 −1 1 1 1 −1 −1 −1 −1 1 −1
31 −1 1 1 1 1 −1 −1 −1 −1 −1 1
32 1 1 1 1 1 1 1 1 1 1 1
Low PCL 300 NO 10 250 82 0* 62.5 62.5 25 65
high PMMA 700 IO 50 1000 250 750 187.5 187.5 62.5 130
Note: *Nanospheres.
Abbreviations: A, kind of polymer; B, velocity of magnetic stirring (rpm); C, kind of oil; D, velocity to transferring the organic phase into aqueous solution (% of the pump 
capacity); E, quantity of 3,5,3′-triiodothyroacetic acid (μg); exp, experiment; F, quantity of polymer (mg); G, quantity of oil (mg); h, quantity of Span™ 60; I, quantity of 
Tween® 80; IO, isodecyl oleate; J, quantity of solvent (mL); K, quantity of water (mL); NO, neem oil; PCL, poly(ε-caprolactone); PMMA, poly(methyl methacrylate).
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preparation was evaluated through relative standard devia-
tion (RSD) calculations for six formulations randomly 
selected. The best selected formulation from the first 211–6 
factorial design was studied in-depth using a 22 factorial 
design, which resulted in four other formulations (Table 2). 
In this second design, the independent variables were the 
quantity of polymer (PMMA) and the presence (750.0 mg, 
0.75% mass/volume) or absence of isodecyl oleate (0.0 mg). 
The quantity of the organic solvent, water, and the surfac-
tants Span 60 and Tween 80 were 25 mL, 65 mL, 187.5 mg, 
and 62.5 mg, respectively. The velocity of magnetic stirring 
(700 rpm) and transfer of the organic phase into the aque-
ous solution (10% of the maxima velocity of the peristaltic 
pump) were kept constant. The amount of Triac was 1 mg. 
The dependent variables were those already reported in the 
211–6 factorial design plus released kinetics.
Physicochemical characterization  
of nanoparticles
Quantification of Triac content in nanoparticles
Triac was assayed by HPLC (1200 Series; Agilent Tech-
nologies, Santa Clara, CA). The HLPC system was config-
ured with a degasser G1322A, quaternary pump G1311A, 
autosampler G1329A, column oven G1316A, and ultravio-
let detector G1314B. Control of the HPLC system and the 
acquisition and processing of data was carried out through 
EZCrom™ SI software (G6702AA; Agilent Technologies). 
The reversed-phase procedure in isocratic mode utilized a 
stainless steel Gemini® C18 column (150 × 4.6 mm inner 
diameter, 5 μm particle size; Phenomenex, Torrance, 
CA) coupled with a C18 (4 × 3 mm inner diameter, 5 μm 
particle size) security guard cartridge (Phenomenex). The 
mobile phase consisted of a mixture of acetonitrile and 
triethylamine buffer 0.1% (40:60 volume/volume), with 
fixed pH 5.6. The column temperature was maintained at 
35°C. The flow rate was 1.0 mL/minute for 10 minutes to 
an injection volume of 20 μL. All experiments were per-
formed at 220 nm.
Preparation of sample solutions and method 
validation
A stock standard solution of 1 mg mL−1 of Triac was pre-
pared by accurately weighing 10 mg of Triac into a 10 mL 
volumetric flask and filling up the volume with methanol. 
A working standard solution (100 μg mL−1) was obtained by 
further dilution of the stock standard solution. Seven  standard 
solutions (5, 10, 20, 40, 60, 80, and 100 μg mL−1), each one in 
triplicate, were obtained by measuring the required amount of 
the working standard solution, being mixed with a sufficient 
quantity of methanol. Similarly, three standard solutions 
(6, 50, and 90 μg mL−1), were each prepared in quintupli-
cate to determine the accuracy and precision of the method. 
The linearity was determined through the calculation of the 
linear regression from the peak area versus the concentration 
plot for the seven standard solutions using the linear least 
squares methodology, and through the analysis of respective 
response factors (ie, peak area divided by concentration of 
each standard sample). The limits of detection (LOD) and 
quantification (LOQ) were calculated mathematically based 
on the relationship between the standard deviation of the 
calibration curve and its slope, by using the multiplier sug-
gested in the International Conference on Harmonization 
standard.15 LOD and LOQ were calculated from the follow-
ing equations:
LOD = (3.3 × Standard deviation/Slope) and 
LOQ = (10 × Standard deviation/Slope).
Pretreatment and analyses of Triac from polymeric 
nanoparticles
Before Triac content was assayed by HPLC on optimized 
chromatographic parameters, it was necessary to develop 
two different pretreatment methods: a specific one to assay 
the total content of Triac in colloidal suspension (absolute 
recovery) and another one to quantify the Triac associated 
with the nanoparticles (entrapment efficiency).
The total content of Triac was determined by the opening 
of nanoparticles dispersed in a colloidal suspension, follow-
ing the procedure described below: 1 mL of chloroform was 
added to 0.5 mL of colloidal suspension and left to rest for 
2 hours. This time was necessary for the total dissolution of 
the polymer with simultaneous delivery of Triac to the disper-
sion medium (solvent). In due course, 0.5 mL of methanol 
was added and the solution was subjected to centrifugation 
at 14,000 rpm for 30 minutes at 30°C (5810 R; Eppendorf, 
Hamburg, Germany) which made the total Triac extraction 
from the polymer possible. Finally, the methanol phase was 
dried (SpeedVac® Plus SC 110A; Savant Instruments Inc, 
Table 2 Values and coded units of 22 factorial design
Experiment Levels Variables
Low High PMMA (mg) Oil* (mg)
33 −1 −1 82.5 0
34 1 −1 250 0
35 −1 1 82.5 750
36 1 1 250 750
Note: *Isodecyl oleate.
Abbreviation: PMMA, poly(methyl methacrylate).
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Farmingdale, NY) and the Triac was resuspended in 0.2 mL 
of methanol that had been analyzed by HPLC.
The entrapment efficiency of the Triac nanoparticles 
was determined by analyzing the concentration of the free 
unloaded compound in the aqueous phase of the colloidal 
suspension. Centrifugation was carried out using the cellulose 
acetate tube filter of the 0.22-μm pore membrane (Costar® 
Spin-X®; Corning Inc, Corning, NY). Approximately 0.5 mL 
of nanoparticle dispersion was placed in the outer chamber 
of the filter assembly. The assembly was then centrifuged at 
5000 rpm for 15 minutes at 15°C. The nanoparticles along 
with encapsulated compounds remained in the outer chamber, 
whereas the aqueous dispersion medium containing the free 
unloaded compounds moved to the sample recovery chamber 
through the filter membrane. After separation, 0.3 mL of 
aqueous dispersion medium was dried. Finally, the product 
was resuspended in 0.2 mL of methanol and the amount of 
free Triac in the dispersion medium was estimated by HPLC. 
The entrapment efficiency was subsequently calculated as 
the equation follows:
Encapsulation efficiency (%) = (Total quantity of Triac  
  −  quantity of free Triac in the aqueous medium) 
/Total  quantity of Triac × 100.
Characterization of suspensions
The physicochemical analysis of nanoparticles was carried 
out immediately after their preparation. After preparing all 
colloidal suspensions, the pH values were determined by 
using a potentiometer (B474; Micronal, Sao Paulo, Brazil). 
The particle size analysis of nanoparticles was performed 
by photon correlation spectroscopy. The photon correlation 
spectroscopy measurements (nm) were carried out at room 
temperature and a fixed angle of 90 degrees. This technique 
yields the mean particle hydrodynamic diameter and the 
polydispersity index, which is a dimensionless measure of 
the broadness of the particle size distribution. The values of 
both the particle size and the zeta potential were measured by 
using Zetatrac® (Microtrac Inc, Montgomeryville, PA) which 
was controlled by Flex version 10.5.0 software (Microtrac). 
For photon correlation spectroscopy and zeta potential (mV) 
measurements, 0.1 mL of each colloidal suspension was 
diluted into 10 mL of ultrapure water and 10 mM sodium 
chloride, respectively. The values reported are the mean 
values for each nanoparticle formulation. These measures 
were carried out at 25°C.
The nanoparticles were dried on polished metal support 
and then gold sputtered after they were examined by scanning 
electron microscopy (SEM) (XL 30 FEG; Philips, Eindhoven, 
Netherlands) at 10 kV, using different magnifications up to 
25,000× .
In vitro release studies of Triac from nanocapsules
In vitro release studies of Triac from nanocapsules in col-
loidal suspension were carried out after some changes in 
the dialysis bag diffusion technique previously described by 
Levy and Benita.16 Dialysis bags (dialysis tubing cellulose 
membrane, 0.4 inches; Sigma-Aldrich) with 1 mL of the 
Triac colloidal suspension were sealed and dropped into 1 L 
of phosphate buffered saline (PBS) at pH 7.4. This solution 
was kept under continuous magnetic stirring. PBS was pre-
pared by dissolving the following salts: 8 g sodium chloride; 
0.2 g potassium chloride; 1.44 g sodium phosphate dibasic 
dihydrate, and 0.24 g of monopotassium phosphate per 1 L 
of ultrapure water. The whole system was kept at 35°C and 
on continuous stream at 3 mL/minute. The stream was con-
trolled by a peristaltic pump (PumpPro TPM 600). At given 
time intervals, a dialysis bag was withdrawn from the stirred 
release medium and the Triac content was directly assayed by 
the previously validated HPLC method. The values reported 
were the mean values of three different batches.
Results and discussion
Significant efforts have been applied to research in nanotech-
nology to make new ways of drug vectorization of molecules 
such as hormones, antitumors, and antimicrobials available, 
as well as make macromolecules such as polysaccharides, 
proteins, and peptides deliver into specific tissues or target 
cells.11,17
The nanoprecipitation method involves the precipitation 
of a preformed polymer from an organic solution with the 
diffusion of this organic solvent into the aqueous medium. 
All formulations presented a macroscopic homogeneous 
aspect like a bluish white milky opalescent fluid (Tyndall 
effect) as a result of the nanoparticle formation as soon as 
the organic phases were diffused into the aqueous phase, in 
agreement with results previously reported for other nanopar-
ticle systems.13,18 This observation confirms the formation of 
nanoparticles. The polymer was dissolved in a water-miscible 
solvent of intermediate polarity, leading to the precipitation 
of nanospheres (absence of oil) and nanocapsules.  Polymeric 
deposition occurs in the interface between the water and 
organic solvent caused by fast diffusion of the solvent, which 
leads to the instantaneous formation of a colloidal suspension. 
The solvent displacement technique allows the preparation 
of nanocapsules when a small volume of nontoxic oil is 
incorporated into the organic phase.11,19
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Through the nanoprecipitation technique proposed by 
Fessi et al,13 it was possible to make several colloidal sus-
pensions of nanospheres and nanocapsules to both PCL and 
PMMA loaded with Triac. This technique has been depicted 
to be simple as well as very reproducible. The better formu-
lations have shown absolute recovery and entrapment effi-
ciency higher than 90%, demonstrating a high performance 
of the nanoprecipitation technique to Triac. High loading 
efficiencies are generally reported for lipophilic drugs when 
nanoparticles are prepared.11,19
In the formulations proposed for the current study, it 
was possible to prepare colloidal suspension containing up 
to 20 μg mL−1 (32.2 μM) of Triac. This concentration was 
nearly 5000 times higher than a simple Triac soluble in aque-
ous medium (4.0 × 10−3 μg mL−1). Triac dispersion in the 
colloidal suspension prepared in this work can be increased 
or decreased by controlling the water quantity in the final 
volume of the preparation.
The PCL and PMMA polymers are considered to be 
biocompatible materials.4 Pharmaceutical nanotechnology 
focuses on formulating therapeutically active agents in bio-
compatible nanoforms.20 Thus, PCL and PMMA are safe and 
desirable for biological experiments. The spherical shape of 
nanoparticles was confirmed by using SEM. In order to obtain 
good resolution through SEM, it was necessary to remove all 
the water from the colloidal suspension after being added to 
the polished metal support. This process caused the gather-
ing of nanoparticles, and polymeric pellicle was formed as 
a result. However, it was possible to observe nanoparticles 
on the polymeric pellicle (Figure 1).
Analytical validation
The investigation of both absolute recovery and entrap-
ment efficiency variables was made possible by using the 
HPLC method. Therefore, the applicability of the method 
was checked by analytical validation according to the Inter-
national Conference on Harmonization.15 The parameters 
investigated were as follows: specificity, linearity and range, 
accuracy and precision, LOD, and LOQ. The specificity of 
the method was evaluated by comparing the chromatograms 
of prepared nanoparticle samples containing the active com-
pound with prepared nanoparticle samples without Triac 
(Figure 2). No interfering peak was observed in 4.55 minutes 
in the blank chromatogram (retention time of Triac) at a 
wavelength of 220 nm. In this sense, the method may be 
considered to be specific for the desired analysis since no 
interference peaks were observed. The analytical calibration 
curves (n = 3) were linear over the concentration range from 
5–100 μg mL−1 (Figure 3).
Linearity was assessed through calculating the regres-
sion equation (y = ax + b) and the correlation coefficient 
(r2) by the least squares method, where: y = (64.94 ± 0.1834)
x + (30.17 ± 8.143) and r2 = 0.9996; “y” represents the area of 
the chromatographic peak and “x” represents the concentra-
tion of standard solution in μg mL−1. The standard deviations 
of the values of “a” and “b” are indicated in the parentheses. 
When r2 values are greater than 0.999 it indicates a good 
linearity of all the concentrations used and a homoscedastic 
distribution of replicates at all levels applied in the calibration 
curve assembly. The quality of linearity was also evaluated 
through analysis of the response factor (Figure 3). The visual 
appearance of the chart and the value of the linear regression, 
which were obtained by plotting the response factors of each 
standard solution of the established work range versus the 
concentration of the standard solutions (Figure 3), revealed 
a slope (−0.03) close to zero and 2.3% of the RSD between 
all levels of the concentration patterns, thus enhancing the 
evaluation of the linearity of the method. Therefore, samples 
may be adequately analyzed within the concentration range 
of the proposed method.
Accuracy was analyzed by calculating the average per-
centage recoveries for Triac at three different concentrations. 
The three standard solutions (6, 50, and 90.0 μg mL−1) were 
each carefully prepared in quintuplicate and analyzed by 
A B C
Figure 1 Scanning electron microscope images of poly(methyl methacrylate) nanocapsules containing 3,5,3′-triiodothyroacetic acid at different magnifications: (A) 6250×; 
(B) 12,500×, and (C) 25,000×.
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Figure 2 Typical chromatogram of a suspension of polymeric nanoparticles with 
and without (blank) 3,5,3′-triiodothyroacetic acid.
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Figure 3 Linearity for the quantitative method of 3,5,3′-triiodothyroacetic 
acid analysis by high-performance liquid chromatography. (A) Calibration curve 
obtained with 3,5,3′-triiodothyroacetic acid standard solutions (n = 21); and 
(B) 3,5,3′-triiodothyroacetic acid response factor versus concentration of 3,5,3′-
triiodothyroacetic acid standard solution (n = 21).
the proposed method in three nonconsecutive days. These 
concentrations were chosen as they covered the linear work-
ing range. The same solutions were used to calculate the 
precision. The total average recovery (accuracy) and RSD 
was 99.3% ± 1.23%, showing strong agreement between 
the experimental and theoretical values. The precision was 
represented by RSD. RSD for repeatability at each concentra-
tion level of standard solutions on each day (n = 5) and for all 
days (n = 15) were lower than 1.17% and 1.76%, respectively. 
The results indicate good precision of the analytical method. 
Detailed results for the three concentration levels tested are 
shown in Table 3.
LOD and LOQ were calculated in accordance with the 
standard deviation of the response (32.07) and slope of the 
calibration curve (64.94). They were found to be 1.3 μg mL−1 
and 3.8 μg mL−1, respectively. The validated method was 
successfully applied in the evaluation of both the absolute 
recovery and the entrapment efficiency of Triac in polymeric 
nanoparticles. The pretreatments were shown to be effective 
for the quantification of the total content of Triac, showing 
a high efficiency of the solvent mixture and time used to 
extract this compound in each of the colloidal suspensions 
which were prepared, and also to analyze the amount of Triac 
encapsulated. It was possible to obtain recoveries up to 100% 
with regard to the linear calibration curve. These results are 
fundamental for the analysis of whether the target analyte was 
efficiently nanoencapsulated and its solubility and stability 
increased, as well as for the analysis of the kinetic release 
and the tested formulation efficacy. The quantitative results 
are described in Table 3.
Characterization of nanoparticles loaded 
with Triac
The aim of this study was to develop and evaluate processes 
and parameters to prepare nanoparticles loaded with Triac 
by using factorial designs. Two factorial designs, a fractional 
211–6 and another 22, were proposed and developed to look for 
better features for nanoparticles loaded with Triac. For the first 
fractional factorial design 211–6, there were eleven independent 
variables which resulted in 32 experiments. The second 22 
factorial design had two independent variables which resulted 
in four experiments. The last one was carried out by using the 
best formulation identified in the first factorial design, which 
was determined after analysis of the dependent variables. The 
results of the dependent variables for both factorial designs 
are illustrated in Tables 4 and 5, respectively.
The reproduction ability of the nanoprecipitation 
 technique was evaluated by preparing six samples: three 
identical nanospheres (experiment eight, Table 1) and another 
three identical nanocapsules (experiment six, Table 1). The 
dispersion of data was expressed by calculating RSD. The 
values of RSD to pH, particle size, zeta potential, Triac 
absolute recovery, and Triac entrapment efficiency in the 
Table 3 Results of precision for three different concentrations of 
3,5,3′-triiodothyroacetic acid standard solutions
Nominal 
concentration 
(μg mL–1)
Mean concentration μg mL-1/RSD (%)
Precision Accuracy
Day 1 
(n = 5)
Day 2 
(n = 5)
Day 3 
(n = 5)
All days 
(n = 15)
6 5.69/0.001 5.87/1.06 5.72/1.41 5.76/1.45
50 50.8/1.17 49.2/0.512 49.5/1.35 49.8/1.76
90 91.7/1.02 92.2/0.802 91.9/0.490 91.9/0.83
Abbreviation: RSD, relative standard deviation.
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nanospheres were lower than 3.94%, 7.61%, 4.77%, 2.49%, 
and 3.87%, respectively; and in nanocapsules they were lower 
than 2.66%, 8.02%, 4.35%, 3.15%, and 3.64%, respectively. 
As a result of these data, the experimental variations among 
the formulations were considered to be existent when the 
calculated contrasts were higher than the random  dispersion. 
These data depict a satisfactory repeatability of the nanopar-
ticle process.
A technique of the fractional factorial design 211–6, to two-
level factorial design, offers the possibility of investigating 
eleven independent variables. The fixed variables, which are 
described in Table 1, were defined prior to literature review13,18 
and experimental compatibility evaluation for Triac. The 
dependent variables utilized to investigate the colloidal 
dispersion were pH, particle size, polydispersity index, and 
zeta potential. On the other hand, the dependent variables – 
absolute recovery and encapsulation efficiency – were applied 
in the stability and kinetic release studies (Table 4).
The contrasts of each variable and their interactions were 
calculated according to the following equation: contrast 
 variable = y–+ − y––, where y–+ and y–– are the average of pH, par-
ticle size, zeta potential, absolute recovery, and encapsulation 
efficiency at the higher (coded as +1) and lower (coded as −1) 
levels, respectively. In an analysis for a fractioned factorial 
design, the values of the calculated contrasts are confused 
among the effects. In the performed experiments in this work, 
the contrast one, for example, is a confusion of the effect one 
between the third-order and sixth-order interactions.
Analyzing the data of the fractional factorial design 
211–6, it was observed that the pH value is directly related to 
the formulation compounds. The presence of oil is a factor 
that might affect the outcome of the assay. The pH values 
ranged from 4.31–6.56. In due course, through calculation 
of the contrasts, it was possible to observe that this primary 
independent (oil quantity) factor decreased pH by 12%. 
However, the calculation of the contrast for two combined 
variables (second-order interactions) – quantity of Triac and 
oil and quantity of polymer and oil – showed that the pH value 
increased to higher levels of 12% and 9.3%, respectively. In 
average values, there was no difference between nanospheres 
(nanoparticle without oil) and nanocapsules. These effects 
confirm the adsorption of Triac and polymer onto vesicles 
instantly formed by oil.
As soon as the undesirable values of particle size greater 
than 500 nm were excluded, nanospheres and nanocap-
sules with average particle size of 159.6 nm and 285.6 nm, 
respectively, were obtained. Particle size in nanospheres and 
nanocapsules ranged from 83.4–269.7 and 169.8–367.0 nm, 
respectively. These results are in accordance with previous 
work that applied the nanoprecipitation technique.13,18 Particle 
size can have important consequences in pharmaceutical appli-
cations for nanoparticles loaded with Triac. In this case, the 
selection between nanocapsules or nanospheres might occur 
through the stability or solubility of Triac and through the 
Table 4 Results of the ph, particle size, zeta potential, absolute 
recovery, and entrapment efficiency for the 211–6 fractional 
factorial design
Exp pH PS (nm) ζ (mV) AR (%) EE (%)
1 4.46 336.0 −14.6 44.6 98.7
2 6.43 UNC −14.53 96.9 100.5
3 5.17 226.4 15.90 16.0 99.4
4 6.48 367.0 −20.18 44.3 97.9
5 4.47 264.5 −14.12 69.7 97.4
6 6.15 323.0 −29.24 101.5 98.6
7 7.00 516.0 −35.98 107.0 99.0
8 5.76 124.7 −14.53 98.9 98.0
9 4.87 269.7 −18.52 39.7 100.7
10 4.31 597.0 8.01 14.5 97.3
11 4.85 344.0 −18.31 69.6 98.2
12 6.50 174.2 −25.06 97.2 100.3
13 6.41 97.6 −3.40 73.8 98.1
14 6.20 752.0 −19.91 104.5 88.1
15 5.45 533.0 −20.10 79.2 97.8
16 4.75 169.8 −21.17 89.5 99.9
17 4.92 657.0 −39.97 88.2 99.6
18 6.03 137.7 −20.15 99.5 94.4
19 6.10 156.6 −21.06 113.6 84.2
20 6.37 235.6 −42.62 94.3 99.6
21 5.20 83.4 −19.34 105.1 98.6
22 6.42 UNC 13.94 91.1 94.2
23 6.50 241.8 −24.92 90.3 90.8
24 4.88 119.7 −18.49 94.0 98.4
25 6.56 139.2 −18.68 40.8 88.6
26 6.33 727.0 −94.01 40.9 101.1
27 4.50 267.6 −19.20 7.9 105.9
28 5.70 99.6 −15.30 46.2 92.8
29 5.48 821.0 −19.98 70.8 87.8
30 5.95 186.4 −20.84 86.9 91.9
31 4.80 155.0 −20.80 78.7 95.7
32 5.05 517.0 −23.85 103.1 99.0
Abbreviations: AR, absolute recovery; EE, entrapment efficiency; exp, experiment; 
PS, particle size; UNC, uncertain; ζ, zeta potential.
Table 5 Results of the dependent variables for the 22 factorial 
design
Exp pH PS (nm) ζ (mV) AR (%) EE (%)
33 5.86 199,1 −20.51 101.3 90.5
34 5.44 168.0 −17.35 102.7 101.0
35 5.50 342.0 −22.19 82.7 94.2
36 5.69 640.0 −64.23 81.2 90.8
Abbreviations: AR, absolute recovery; EE, entrapment efficiency; exp, experiment; 
PS, particle size; ζ, zeta potential.
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membranes which the nanoparticles need to cross. The particle 
size in nanocapsules is limited by the size of the drops which 
are immediately created (oil core) when the organic phase is 
transferred into the aqueous phase. The oil core is controlled 
by the flow through which the organic phase is poured into 
aqueous solution, as well as the magnetic stirring and viscosity 
of the aqueous phase. Under the same conditions, nanocap-
sules will always have a higher particle size than nanospheres. 
Regarding the size of nanoparticles, not only is their average 
size (nm) important, but also their size variability (polydisper-
sity index). The four best formulations (experiments six, eight, 
20, and 24; Table 4) obtained a polydispersity index lower 
than 0.200. Values of polydispersity index lower than 0.200 
describe good-to-average distribution, taking into account 
that the colloidal suspension is considered to be a homogenic 
suspension. They help to keep the stability of colloidal disper-
sion without the formation of microparticles or precipitates. 
The best colloidal suspensions didn’t precipitate even after 
4 months. This narrow particle size distribution circumvents 
creation of the Triac concentration gradient between small 
and large nanoparticles which could lead to Triac crystalliza-
tion onto large particles, ie, crystal growth known as Ostwald 
ripening.21 The SEM images show a relatively homogenous 
system, which is consistent with the observed polydispersity 
index (Figure 1). The morphological analysis for the best 
selected formulations through SEM revealed the formation 
of spherical particles which showed regular surface and form, 
homogeneity, and lower dispersion in their sizes.
Among the several factors investigated, the quantity of 
polymer, oil, and Span 60 were the most important factors 
regarding the particle size of nanoparticles. They increased 
the particle size up to 24.0%, 31.4%, and 31.0%, respectively. 
Naturally, these results refer to a widening of the polymeric 
shell, the presence of a core vesicle (oil), and the interaction/
dissolution of Span 60 into the oily core. Increase in polymer 
concentration led to an increase in viscosity of the organic 
phase, thereby reducing the net shear stress and promoting 
the formation of droplets with larger size. In addition, the 
increasing viscosity could hinder rapid dispersion of polymer 
solution into the aqueous phase, resulting in larger droplets 
which formed larger nanoparticles after the elimination of 
the organic solvent.22 Tween 80 increases particle size by 
up to 13%. After the removal of the organic solvent, more 
Tween 80 molecules can be physically incorporated onto the 
nanoparticle surface.21 All contrast combinations that showed 
significant variation in particle size were related to these three 
variables. Nanocapsules from isodecyl oleate and PMMA 
were smaller than nanocapsules from neem oil and PCL.
The electrostatic potential (zeta potential) is related to 
the surface charge of the nanoparticles. Nanoparticles with a 
zeta potential between +10 mV and −10 mV are considered 
approximately neutral. On the other hand, nanoparticles with 
a zeta potential higher than +30 mV or lower than −30 mV 
are considered to be very stable in the dispersion medium. 
This variable depicted an average value of −21 mV. Their 
values ranged from 15.9–42.6 mV (except for experiment 26 
which was excluded). Triac and both tensoactives, Span 60 
and Tween 80, caused the main effect on zeta potential. Triac 
and Span 60 decreased zeta potential. On the other hand, 
Tween 80 increased it. Tween 80, an amphiphilic nonionic 
stabilizer, may cause steric stabilization which is dominated 
by the solvation effect.
The average absolute recovery was 74.9%, with a range 
of 7.9% to approximately 100%. The main independent vari-
ables which had effect on absolute recovery were isodecyl 
oleate, PMMA, and the quantity of water, which increased 
absolute recovery by up to 28.6%, 12.1%, and 18.8%, 
 respectively. The combination of several variables (analysis 
of the contrast values in different orders) did not show sig-
nificant results for absolute recovery. When the amount of 
polymer and oil were at a high level, the interaction or affinity 
of Triac probably increased, which lead to a higher absolute 
recovery and entrapment efficiency. The velocity at which 
the organic phase was transferred into the aqueous phase 
decreased absolute recovery by 18.2%. Due to low Triac 
water solubility, higher entrapment efficiencies were obtained 
in this study. The entrapment efficiency for all formulations 
was higher than 84% and the average value was 96.6%. The 
concentration of Triac did not influence this variable. When 
both Triac and the quantity of oil were at a higher level, they 
caused an increase of 13.8% in encapsulation efficiency. 
The encapsulation efficiency was favored by the lipophilic 
feature of Triac, which prefers the oily core and polymeric 
interaction instead of the aqueous medium.
Through the 211–6 fractional factorial design, it was pos-
sible to define both the better independent variables and 
formulations. The best levels were: PMMA, isodecyl oleate, 
10% velocity of transference of the organic phase, 250-μg 
quantity of Triac, 62.5-mg quantity of Span 60, 187.5-mg 
quantity of Tween 80, and 130-mL volume of water. These 
results can be observed in experiments six, eight, 22, and 24 
(Table 4), which depicted the best dependent variables. In 
due course, a new 22 factorial design was analyzed, which 
aimed to search for better information on both polymer and 
isodecyl oleate quantities as well as study the release kinetics. 
In this experiment, the velocity of magnetic stirring was fixed 
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at 300 rpm; the velocity of transference of the organic phase 
into the aqueous phase was 10% of the pump capacity; the 
quantity of Triac, Span 60, and Tween 80 was 1.0, 62.5 and 
187.5 mg, respectively; and the volume of the solvent and 
the water was 25 mL and 130 mL, respectively. In this 22 
factorial design, the independent variables were the quantities 
of PMMA and isodecyl oleate. The results of the dependent 
variables are depicted in Table 5.
In the 22 factorial design, it was possible to observe that 
the quantity of polymer and oil were the main factors to have 
an effect on particle size and zeta potential. Both increase 
the particle size significantly through individual or combined 
effects at a higher level. Nanocapsules showed values of 
particle size and zeta potential (in module) higher than 
those in nanospheres. Higher zeta potential is necessary for 
colloidal stability. However, smaller particle size might be 
favorable for penetrability. On the other hand, no difference 
was observed in either the pH or in the entrapment efficiency 
for both nanocapsules and nanospheres loaded with Triac. 
The quantity of oil is an individual variable that decreases 
the absolute recovery. It is possible that an irreversible 
reaction occurs between Triac and oil. However, when the 
quantity of oil and polymer are at a higher level, no effects 
were observed in absolute recovery. Therefore, experiment 
34 may be considered the best one.
Release kinetics
In these experiments, the release assays provided for all 
formulations of the 22 factorial design were carried out in 
simulated fluid conditions in PBS medium at 35°C, which 
was kept under magnetic stirring with continuous stream. 
The continuous stream system avoids saturation on the 
system.51 In this assay, Triac passes through the pores of the 
membrane while the nanoparticles do not, hence allowing 
observation of the diffusion of Triac. The PBS buffer and 
controlled temperature were selected in order to imitate the 
human biological system. During the assay, aliquots were 
collected at predetermined times and Triac was quanti-
fied by HPLC. The results were expressed in terms of the 
percentage release (Figure 4). The release profile shows 
that the percentage of Triac, which was released at the first 
sampling time of 1 hour, in formulations 33, 34, 35, and 36 
was 60.2%, 36.5%, 39.0%, and 41.6%, respectively. These 
four formulations depicted a fast release kinetic during the 
first hour. This probably occurs through fast migration of 
the Triac adsorbed on the polymeric nanoparticle surface 
or positioned in the superficial polymeric layer.24 After the 
first hour, formulations 34, 35, and 36 showed constant 
and slow release rate and the total percentage of release 
after 10 hours was 52.8%, 53.8%, and 52.7%, respectively. 
Only formulation 33 depicted 100% release after 10 hours. 
Mousa et al and Yalcin et al described the preparation of 
nanoparticles of the poly(lactic-co-glycolic acid) loaded with 
thyroid hormone, but did not show results for the release 
kinetic mechanism.25,26
The nanospheres formulated at high PMMA level showed 
a similar mechanism and release rate as the nanocapsules 
prepared using isodecyl oleate. The presence of a higher 
quantity of polymer and/or oil may increase the length of 
diffusional pathways of the Triac loaded in the nanoparticles 
towards the aqueous phase. Furthermore, the existence of an 
interaction between the compound and the polymer of the 
nanoparticles may be suggested.52 As a result, there may be 
a reduction on the release rate.
Mathematical modeling (zero order, first order, and 
biexponential) was applied to obtain information about the 
kinetics of Triac dissolution and release behavior. After 
adjusting these models, the best profile was selected based 
on the highest r2. According to these criteria, biexponential 
(second order) was the best model to describe the dissolution 
and release profiles for nanoencapsulated Triac in formula-
tions 34, 35, and 36. For formulation 33, the best model 
was monoexponential (first order). In these cases, the biex-
ponential model may originate from an interaction between 
Triac and other formulation compounds such as polymer 
and/or oil quantity. On the other hand, the monoexponential 
model is only affected by Triac concentration. The mono-
exponential model was observed in the formulation which 
did not contain oil but had a tested lower polymeric level. 
The variation between these two models proposes ways to 
control both the release rate and Triac concentration in the 
human biological system.
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Figure 4 In vitro release profile of 3,5,3′-triiodothyroacetic acid from 
nanoparticles.
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Conclusion
In the present study, the preparation and characterization of 
nanospheres and nanocapsules loaded with Triac aimed at a new 
approach for formulation and release kinetics. For simultaneous 
analysis of the influence of different contrasts and factors on 
the properties of the nanoparticles and to find optimum formu-
lations, the formulation was optimized by using two factorial 
experimental designs. The influence of the kind and quantity of 
polymer and oil on drug loading was demonstrated. The opti-
mum formulation with the highest Triac loading was achieved 
by using PMMA. There was no difference between nanocapsule 
and nanosphere loading or absolute recovery amount in the best 
formulations. The HPLC method developed and validated was 
satisfactory in analyzing the absolute recovery and entrapment 
efficiency. A colloidal suspension containing up to 20 μg mL−1 
(32.2 μM) of Triac was able to be prepared. For different for-
mulations, variable release rates were identified in a normal 
leaching study in PBS buffer.
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